These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 6113824)

  • 21. [The diagnostic validity of screening tests and laboratory markers in alcohol use disorders].
    Gül S; Akvardar Y; Taş G; Tuncel P
    Turk Psikiyatri Derg; 2005; 16(1):3-12. PubMed ID: 15793693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The value of laboratory tests for the screening and recognition of alcohol abuse in primary care patients.
    Hoeksema HL; de Bock GH
    J Fam Pract; 1993 Sep; 37(3):268-76. PubMed ID: 8105021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Biological disorders of alcoholic origin].
    Stoffels G; Pelc I; Brauman J; Verbanck M
    Acta Psychiatr Belg; 1975 Mar; 75(2):173-81. PubMed ID: 1233871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gamma-glutamyltranspeptidase, aspartate aminotransferase, and erythrocyte mean corpuscular volume as indicators of alcohol consumption in liver disease.
    Eriksen J; Olsen PS; Thomsen AC
    Scand J Gastroenterol; 1984 Sep; 19(6):813-9. PubMed ID: 6151242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical and haematological markers of alcohol intake.
    Whitehead TP; Clarke CA; Whitfield AG
    Lancet; 1978 May; 1(8071):978-81. PubMed ID: 76902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significant correlation between insulin resistance and serum gamma-glutamyl transpeptidase (gamma-GTP) activity in non-drinkers.
    Yokoyama H; Hirose H; Moriya S; Saito I
    Alcohol Clin Exp Res; 2002 Aug; 26(8 Suppl):91S-94S. PubMed ID: 12198383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carbohydrate-deficient transferrin as a marker of change in alcohol intake in men drinking 20 to 60 g of alcohol per day.
    Burke V; Puddey IB; Rakic V; Swanson NR; Dimmitt SB; Beilin LJ; Ching S; Beilby JP
    Alcohol Clin Exp Res; 1998 Dec; 22(9):1973-80. PubMed ID: 9884140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Persons with known alcohol problems. Screening procedures for alcohol consumption].
    Duckert F; Amundsen A; Johnsen J; Mørland J; Strømme JH
    Tidsskr Nor Laegeforen; 1987 Jan; 107(1):62-5. PubMed ID: 2881372
    [No Abstract]   [Full Text] [Related]  

  • 29. Biomarkers of liver status in heavy drinkers, moderate drinkers and abstainers.
    Alatalo P; Koivisto H; Puukka K; Hietala J; Anttila P; Bloigu R; Niemelä O
    Alcohol Alcohol; 2009; 44(2):199-203. PubMed ID: 19054785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Why take fasting blood samples for laboratory diagnosis? Behavior of various laboratory parameters in postprandial blood samples].
    Bloedner CD
    Fortschr Med; 1984 Nov; 102(44):1123-7. PubMed ID: 6151934
    [No Abstract]   [Full Text] [Related]  

  • 31. Diagnostic tests for alcohol consumption.
    Conigrave KM; Saunders JB; Whitfield JB
    Alcohol Alcohol; 1995 Jan; 30(1):13-26. PubMed ID: 7748270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alcohol addiction: evaluation of alcohol abstinence after a year of psycho-medical-social treatment.
    Giuffredi C; Di Gennaro C; Montanari A; Barilli A; Vescovi PP
    Addict Biol; 2003 Jun; 8(2):219-28. PubMed ID: 12850781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the combined marker GGT-CDT and the conventional laboratory markers of alcohol abuse in heavy drinkers, moderate drinkers and abstainers.
    Hietala J; Koivisto H; Anttila P; Niemelä O
    Alcohol Alcohol; 2006; 41(5):528-33. PubMed ID: 16799164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimation of alcohol intake from laboratory results.
    Whitfield JB; Hensley WJ; Bryden D; Gallagher H
    Ann Clin Biochem; 1978 Nov; 15(6):304-6. PubMed ID: 32827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Yield of laboratory tests in the detection of excessive drinkers in the work place].
    Aubà J; Serrano M; Frutos D; Mira M
    Med Clin (Barc); 1993 Jan; 100(1):5-8. PubMed ID: 8094106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of laboratory markers and the audit questionnaire by primary care physicians to detect alcohol abuse by patients.
    Aalto M; Seppä K
    Alcohol Alcohol; 2005; 40(6):520-3. PubMed ID: 16215269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum gamma-glutamyl transferase in alcoholics, moderate drinkers and abstainers: effect on gt reference intervals at population level.
    Hietala J; Puukka K; Koivisto H; Anttila P; Niemelä O
    Alcohol Alcohol; 2005; 40(6):511-4. PubMed ID: 16131497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [On the problems of the consumption of alcohol in the brewing industry (author's transl)].
    Zober A; Bost HP; Weltle D
    Zentralbl Bakteriol B; 1979 Jun; 168(5-6):422-41. PubMed ID: 41383
    [No Abstract]   [Full Text] [Related]  

  • 39. Correlation between insulin resistance and gamma-glutamyl transpeptidase sensitivity in light drinkers.
    Moriya S; Yokoyama H; Hirose H; Ishii H; Saito I
    Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):52S-57S. PubMed ID: 12960508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [B-PEth and other markers of excessive alcohol us. A comparative study in general practice].
    Bjerre B
    Lakartidningen; 2009 Apr 7-21; 106(15-16):1099-100, 1102-3. PubMed ID: 19492677
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.